Production and application of lyophilized urine samples used in microbiology external quality assessment programme in Vietnam

MedPharmRes ◽  
2021 ◽  
Vol 5 (2) ◽  
pp. 29-35
Author(s):  
Diep Tuan Tran ◽  
Huy Quang Vu ◽  
Tuan Minh Huynh ◽  
Chuong Van Le ◽  
Huu Minh Vu

Introduction: The external quality assessment (EQA) for microbiological laboratories is one of the most commonly used services for quality assurance. In Vietnam, the majority of EQA samples are imported from foreign markets, involving high costs, complicated procedures and further making it difficult to ensure quality in terms of transport and management. The objective of this study was to develop a process for producing lyophilized urine samples containing pathogens (Escherichia coli and Enterococcus faecalis), evaluating the homogeneity and stability of the produced samples and the subsequent application of these samples in the launching trial program of the clinical microbiology program. Methods: The production process of was established according to ISO Guide 34:2009. The homogeneity and stability of production samples were evaluated according to the guidance of ISO 13528:2015. Produced samples were preserved at 2-8°C and assessed for stability after 2, 4, 6, 8, 10, and 12 weeks. Samples were subsequently utilized in the clinical microbiology EQA program, wherein they were sent to 26 laboratories located in several different regions across Vietnam. Results: The production process thus conceived comprised eight steps that ensured the homogeneity of the samples produced. Two sets of quality samples were produced and stability within12 weeks. Approximately 92% of the laboratories met the set target. Conclusions: The eight-step process to produce presumptive lyophilized urine samples has successfully developed. The produced samples reach the criteria for EQA samples and suitable to apply on clinical microbiology EQA scheme at national scale.

2014 ◽  
Vol 36 (3) ◽  
pp. 122-139 ◽  
Author(s):  
Young Jin Ko ◽  
Mi-Na Kim ◽  
Eui Chong Kim ◽  
Jong Hee Shin ◽  
Nam Yong Lee ◽  
...  

2014 ◽  
Vol 19 (5) ◽  
pp. 397-401
Author(s):  
Ya L. Xiao ◽  
Chuan B. Zhang ◽  
Hai J. Zhao ◽  
Feng F. Kang ◽  
Wei Wang ◽  
...  

2016 ◽  
Vol 38 (4) ◽  
pp. 169-193 ◽  
Author(s):  
Jeonghyun Chang ◽  
Mi-Na Kim ◽  
Eui Chong Kim ◽  
Jong Hee Shin ◽  
Nam Yong Lee ◽  
...  

2012 ◽  
Vol 50 (2) ◽  
Author(s):  
Adriaan J. van Gammeren ◽  
Corrie van Haperen ◽  
Aldy W.H.M. Kuypers

AbstractAn increase in urine calcium compared to the consensus value was observed in some urine samples of the Dutch External Quality Assessment Scheme (EQAS). It appeared that the increase was due to the addition of oxalate by the EQAS organizers and preanalytical acidification of the samples by some of the participants. Because of this observation, the effect of urine acidification on urine calcium level in EQAS and patient samples with added oxalate was investigated.Twenty-four EQAS urine samples and 20 patient urine samples were subject to recovery measurements of urine calcium before and after addition of sodium oxalate and acidification.Differences in urine calcium between acidified and non-acidified samples up to 30.9% have been observed in EQAS samples with added oxalate. Patient samples show differences up to 80%. Differences between acidified and non-acidified samples are minimal for low calcium oxalate levels but increase with higher levels. Samples without added oxalate show equal urine calcium results between acidified and non-acidified samples.Urine calcium results are decreased in non-acidified samples with an excess of oxalate. In case of hyperoxaluria, acidification of patient urine collections and EQAS samples is recommended for correct urine calcium values.


2015 ◽  
Vol 37 (4) ◽  
pp. 153-178 ◽  
Author(s):  
Young Jin Ko ◽  
Mi-Na Kim ◽  
Eui Chong Kim ◽  
Jong Hee Shin ◽  
Nam Yong Lee ◽  
...  

Author(s):  
María Antonia Llopis ◽  
Josep Miquel Bauça ◽  
Nuria Barba ◽  
Virtudes Álvarez ◽  
Montserrat Ventura ◽  
...  

Abstract Background: Preanalytical variables, such as sample collection, handling and transport, may affect patient results. Preanalytical phase quality monitoring should be established in order to minimize laboratory errors and improve patient safety. Methods: A retrospective study (2001–2013) of the results obtained through the Spanish Society of Clinical Biochemistry and Molecular Pathology (SEQC) External quality assessment (preanalytical phase) was performed to summarize data regarding the main factors affecting preanalytical phase quality. Our aim was to compare data from 2006 to 2013 with a previously published manuscript assessing the 2001–2005 period. Results: A significant decrease in rejection rates was observed both for blood and urine samples. For serum samples, the most frequent rejection causes in the first period were non-received samples (37.5%), hemolysis (29.3%) and clotted samples (14.4%). Conversely, in the second period, hemolysis was the main rejection cause (36.2%), followed by non-received samples (34.5%) and clotted samples (11.1%). For urine samples, the main rejection cause overall was a non-received sample (up to 86.1% of cases in the second period, and 81.6% in the first). For blood samples with anticoagulant, the number of rejections also decreased. While plasma-citrate-ESR still showed the highest percentages of rejections (0.980% vs. 1.473%, p<0.001), the lowest corresponded to whole-blood EDTA (0.296% vs. 0.381%, p<0.001). Conclusions: For the majority of sample types, a decrease in preanalytical errors was confirmed. Improvements in organization, implementation of standardized procedures in the preanalytical phase, and participation in a Spanish external quality assessment scheme may have notably contributed to error reduction in this phase.


Sign in / Sign up

Export Citation Format

Share Document